Taconic Capital Advisors’s NKGen Biotech, Inc. Common Stock NKGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-350,000
| Closed | -$3.48M | – | 329 |
|
|
2022
Q4 | $3.48M | Hold |
350,000
| – | – | 0.1% | 194 |
|
|
2022
Q3 | $3.41M | Hold |
350,000
| – | – | 0.08% | 244 |
|
|
2022
Q2 | $3.4M | Hold |
350,000
| – | – | 0.09% | 253 |
|
|
2022
Q1 | $3.4M | Hold |
350,000
| – | – | 0.09% | 240 |
|
|
2021
Q4 | $3.39M | Hold |
350,000
| – | – | 0.1% | 201 |
|
|
2021
Q3 | $3.39M | Buy |
+350,000
| New | +$3.39M | 0.09% | 150 |
|